Back to search

Article

Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypes

2021-08-25

Abstract excerpt

Alpha-synuclein (aSyn) is assumed to be a central player in the pathogenesis of synucleinopathies due to its accumulation in typical protein aggregates in the brain. However, it is still unclear how it contributes to neurodegeneration. Type-2 diabetes mellitus is a risk factor for Parkinson’s disease and, one common molecular alteration among these disorders is an age-associated increase in protein glycation. Thus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3b134eaa-3c0d-5bef-9f80-db658e319d84
DOI
10.1101/2021.08.24.457507
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Glycation modulates glutamatergic signalling and exacerbates Parkinson’s disease-like phenotypesDOI 10.1101/2021.08.24.457507
Select a neighboring publication to make it the new centre.